Cel Sci CVM
NYSE CVM
$1.47 +0.01 (+0.68%)
As of: Aug 21, 2026 · 12:59 PM EDT

Cel Sci (CVM) Operating Margin Growth (1y) (2011 - 2017)

Cel Sci (CVM) Operating Margin Growth (1y) (2011 - 2017) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.69 Bn 131.84 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 86.54 Bn 78.54 Bn 3.93 Bn 78.00
3 Argenx Se 65.27 Bn 60.09 Bn 1.37 Bn 1,135.00
4 Moderna 59.41 Bn 54.27 Bn 52.00 Mn 7,666.00
5 BeOne Medicines 42.12 Bn 37.02 Bn 1.53 Bn 1,238.00
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn 2,002.00
7 BioNTech SE 28.07 Bn 9.68 Bn 668.28 Mn -3,558.00
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 29,091.00
9 Royalty Pharma 27.28 Bn 26.44 Bn - -1,651.00
10 Cel Sci 2.18 Mn -4.36 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2017 -2.28 Mn
Sep 30, 2011 148,308.00